ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Palladyne AI Corporation

Palladyne AI Corporation (STRC)

2.46
0.00
( 0.00% )
Updated: 20:00:00

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
2.46
Bid
2.27
Ask
2.40
Volume
-
0.00 Day's Range 0.00
0.3982 52 Week Range 3.25
Market Cap
Previous Close
2.46
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
1,193,042
Shares Outstanding
25,900,000
Dividend Yield
-
PE Ratio
-0.55
Earnings Per Share (EPS)
-4.46
Revenue
6.15M
Net Profit
-115.59M

About Palladyne AI Corporation

Sarcos Technology & Robotics Corp is an industrial robotics company and is focused on doing things a little differently. It augments human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and produc... Sarcos Technology & Robotics Corp is an industrial robotics company and is focused on doing things a little differently. It augments human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Its mobile robotic systems, the Guardian S, Guardian GT, Guardian XO, and Guardian XT, are designed to revolutionize the future of work wherever physically demanding work is done. Show more

Sector
General Indl Mach & Eq, Nec
Industry
Blank Checks
Website
Headquarters
Wilmington, Delaware, USA
Founded
2021
Palladyne AI Corporation is listed in the General Indl Mach & Eq sector of the NASDAQ with ticker STRC. The last closing price for Palladyne AI was $2.46. Over the last year, Palladyne AI shares have traded in a share price range of $ 0.3982 to $ 3.25.

Palladyne AI currently has 25,900,000 shares outstanding. The market capitalization of Palladyne AI is $63.71 million. Palladyne AI has a price to earnings ratio (PE ratio) of -0.55.

STRC Latest News

Palladyne AI Ticker Symbol now PDYN

Palladyne AI Corp. (“Palladyne AI” and formerly Sarcos Technology and Robotics Corporation) (Nasdaq: PDYN and PDYNW and formerly Nasdaq: STRC and STRCW) today announced that effective as of the...

JPMorgan boosts dividends, Chipotle unveils 50:1 stock split, and Latest News

JPMorgan Chase (NYSE:JPM) – JPMorgan surprised by increasing its dividends by 9.5%, reflecting a record profit and the potential easing of capital rules by regulators. The largest US bank...

Sarcos Robotics is Now Palladyne AI

Rebranding Emphasizes New Focus on Brain over Brawn Palladyne AI is Commercializing Advanced AI Software that Enables Robots to Observe, Learn, Reason and Act Like Humans Sarcos Technology and...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40.3818.26923076922.082.621.66755465422.12289852CS
121.9246359.4695554730.53543.250.450211930421.61138015CS
261.74241.6666666670.723.250.39825509231.52798522CS
52-0.3846-13.52035435562.84463.250.39824930701.73360139CS
156-57.48-95.895895895959.94630.398241065011.47527116CS
260-57.48-95.895895895959.94630.398241065011.47527116CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.381
(0.00%)
3
AADRAdvisorShares Dorsey Wright ADR ETF
$ 59.84
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.80
(0.00%)
254
AACIArmada Acquisition Corporation I
$ 11.17
(0.00%)
0
AACGATA Creativity Global
$ 1.03
(0.00%)
73
AAGRAfrican Agriculture Holdings Inc
$ 0.381
(0.00%)
3
AADRAdvisorShares Dorsey Wright ADR ETF
$ 59.84
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.80
(0.00%)
254
AACIArmada Acquisition Corporation I
$ 11.17
(0.00%)
0
AACGATA Creativity Global
$ 1.03
(0.00%)
73
EGOXNext e GO NV
$ 0.036
(0.00%)
34.07M
AGBAAGBA Group Holding Ltd
$ 1.03
(0.00%)
21.44M
ZCMDZhongchao Inc
$ 1.45
(0.00%)
17.22M
SINTSiNtx Technologies Inc
$ 0.04
(0.00%)
12.77M
SQQQProShares UltraPro Short QQQ
$ 12.07
(0.00%)
9.67M

STRC Discussion

View Posts
glenn1919 glenn1919 2 weeks ago
STRC............................................https://stockcharts.com/h-sc/ui?s=STRC&p=W&b=5&g=0&id=p86431144783
👍️0
NebulaMountain30 NebulaMountain30 2 weeks ago
Wonder if full credit pay worldwide?
Forte on the website, with the AI adaptation a stroke of genius. I would say it's a guarantee!!!
👍️0
maverick one maverick one 3 weeks ago
I’m a long time investor and I started shorting this after it came out of SPAC/ then flip it -years ago- I rode it all the way down before the RS- and just bc the Wolfe man has allegedly “came back “ and the lady - doesn’t mean jack sheet imo.

They’ve had a tough time burning through hundreds of millions and exoskeletons were never a success - then they bought the Pittsburg robot underwater company blah blah blah. Then ok - now their allegedly an AI company and Wolfeman is now back for it?

It’s a hot mess and always has been with a chicken with its head cut off- looks like chicken is still upright on its feet running all over the place still. I’m not impressed by the head fake rise in PPS either.

Don’t be gullible imo on PR’s they never executed their plan coming out of a pure R & D, to a exoskeleton company producing massive number of suits. It was an extremely tall task to do and imo - they failed badly.

Now LOL wait - it’s a AI company? Ok...good luck on that. Show me the money at $25 + pps and other than that - I’m NOT swallowing the Jim Jones kool aid. Too smart and experienced.

However I am deep up to my neck in shares and got them paid for by shorting for many many years and flipping. I’m in ccccchhhhheeeeaaaapppp- regardless. So their failings enriched my accounts and for that I thank them. However I am loaded like loaded at the very very very bottom. :)))

I think there will be much more helter skelter and I’m banking on it - I’ll profit off it as I’ve done from day 1. If I can help drag them back down to less than a $1 and they get more Nasdaq notices not in compliance - LOL - pop the champagne bottles.

If your going to run a public trader company get over $400 million + probably should execute on behalf of its shareholders. But I saw trouble and I rode it down.
👍️0
glenn1919 glenn1919 4 weeks ago
STRC.......................................https://stockcharts.com/h-sc/ui?s=STRC&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 1 month ago
STRC.............................https://stockcharts.com/h-sc/ui?s=STRC&p=W&b=5&g=0&id=p86431144783
👍️0
GhosTraderX GhosTraderX 1 month ago
Here comes 3.0+

GhosT
👍️0
Ricorich Ricorich 1 month ago
STRC the power of attraction.
👍️0
GhosTraderX GhosTraderX 2 months ago
Three Solid Days so far...

GhosT
👍️0
Invest-in-America Invest-in-America 2 months ago
STRC: Has been near (or at) the TOP of this list for many days now ---
https://www.barchart.com/investing-ideas/penny-stocks?orderBy=percentChange5d&orderDir=desc
👍️0
glenn1919 glenn1919 2 months ago
STRC...................................https://stockcharts.com/h-sc/ui?s=STRC&p=W&b=5&g=0&id=p86431144783
👍️0
boston127 boston127 2 months ago
Good day yesterday. Love their products.

Will continue to review, but the company is a minus $27M in value. Tough to move too quickly here.
👍️0
Awl416 Awl416 2 months ago
Impressive
👍️0
TheFinalCD TheFinalCD 2 months ago
.61
👍️0
maverick one maverick one 5 months ago
Incorrect monk - it’s was in .30’s before the reverse split recently several months ago and declined rapidly which I predicted and knew it would.
👍️0
Monksdream Monksdream 6 months ago
STRC new 52 week low
👍️0
Monksdream Monksdream 6 months ago
STRC 52 week low
👍️0
maverick one maverick one 7 months ago
They had hundreds of millions in SPAC- they had plenty of backing and time from serious backers - they imo really to date burned through so much $ and have not brought to market literally nothing of value as far as production imo.

They have ran out of 2 things that something that you one can never buy- TIME & FAITH.

I called this decline before it struck a dollar months ago and a RS was likely to keep it traded on big board. I’m calling a second RS again and if not - it might imo possibly get delisted & forced to the OTC market.

So much potential and yes I still believe robots exoskeletons will be here to stay- I’m not just sure if Sarcos will be a major player in doing that.

This has shorty written all over it and I’ve been using both trade options for many months.
👍️0
Monksdream Monksdream 7 months ago
The morph strategy worked
👍️0
Monksdream Monksdream 7 months ago
STRC new 52 week low
👍️0
Monksdream Monksdream 7 months ago
This is par for the course with high risk start ups
They just morph into something else
👍️0
maverick one maverick one 7 months ago
Not true it was in the .30’s couple months ago when they did a big RS- which I predicted was coming to remain above $1 to meet requirements.

Just like I said they would exactly do that and just as I predicted it would FALL once again after a RS below a $1.

This company is in deep trouble with exoskeletons and never delivered on any of that to market and sold any.

I’m going to short.

Great ideas, but it was a pure R & D, which raised hundreds of millions in a SPAC- and has seriously struggled to date burning through that $ raised.

Now their latest Hail Mary is starting a new division allegedly AI.

It could work, I’m still in their corner bc I think their going toward the future. It’s just however, with pulling back guidance and there’s a possibility this gets dumped to OTC or another massive 2nd RS could be coming - I’m shorting. If positive news comes which lifts it- I’ll go back green. Cover my puts.
👍️0
Monksdream Monksdream 7 months ago
STRC new 52 week low
👍️0
Monksdream Monksdream 7 months ago
STRC new 52 week low
👍️0
Monksdream Monksdream 7 months ago
STRC new 52 week low
👍️0
Monksdream Monksdream 7 months ago
STRC new 52 week low
👍️0
maverick one maverick one 8 months ago
Signs of underlying weakness- Now it’s hitting ranges of $1.19 - $1.25....if they don’t turn the ship around very very soon . I can see this trading under a dollar for a length of time - if it does it will trigger another Nasdaq delisting notice - catastrophic and what WILL they do? OF COURSE WHAT ELSE !!! What another RS to boost it over a dollar?

Naw I’ll pass - not until see I see exo suits sold and booked. This AI alleged biz- they just started will be the only thing that might boost or save their company for now - bc if their relying on exo suits without sales - that’s not going to occur right away.

I’m highly disappointed to date since I first became aware of Sarcos filing for a SPAC. They really need to get those suits fine tuned, into production and SOLD.

Enough of the malarkey. However I am a fan of the company and it’s potential - I want them to succeed and pulling for them - I do want to buy and long term hold - but there is weakness in PPS even though it swung to upside recently.

I don’t want to lose any money or shares through a potential new RS if the weakness continues and slides and stays below a dollar again. I could see or imagine their institutional investors likely are looking at them going- hey what’s up?
👍️0
maverick one maverick one 8 months ago
I smell desperation and decline bc after burning through hundreds of millions and a acquisition / the acquisition imo will in no way will service the debt factor servicing of it. They have not turned a corner in their alleged exoskeletons as of yet and they embarrassingly had to withdraw their future guidance earnings.

How is this a positive look to Wall Street, institutional investors and retail buyers? Answer / it is not.

Now ALL of a sudden announcing in the biz of Ai? Now it’s what back down to a $1.41 close? What’s next - their going to get into manufacturing of toasters/blenders? It’s a never ending situation and STILL they trot out to all these conventions - but yet no major exo suits or booked sales. Imo looking more and more like they can’t imo execute their visions. This was a pure spec R & D play - what is it exactly now? Highly dissatisfied with the lack of Corp execution on mgmt’s part so far. I think IMO it’s a continuing mixed signals here coming from leadership.

Major red flag imo.
👍️0
tw0122 tw0122 9 months ago
Higher…
👍️0
Monksdream Monksdream 9 months ago
STRC new session high
👍️0
Monksdream Monksdream 9 months ago
STRC in progress
👍️0
maverick one maverick one 9 months ago
Now their RS a crappy 1-6, gee sign me up. They have not met benchmarks for exo skeleton and now it’s an alleged AI/software branch being developed. Could you imagine if you were an investor at very beginning buying in at that early way over priced PPS? Just to watch the thing sink like a rock throwing into a pond LOL omg. I’d gone bananas. Just to watch the blood bath in PPS decline over and over predictably. Honestly - I can’t understand how their still around.

So what are they? They were far over hyped in the beginning slick media and hitting trade shows doesn’t equate actual production of suits brought to market and SALES. The RE2 acquisition isn’t a game changer right away and likely imo won’t be. It’s be like yeah thanks for stopping by our booth at the trade show - but for years we can’t produce and sell any - but hey cool right LOL? Look at the demonstrations. It’s the future. It’s safety. That doesn’t mean jack - all trade shows in world - if they can’t execute.

They have burnt through predictably and insane amount of OTHER PEOPLES MONEY hundreds of millions and yet they don’t have any exo skeleton massive production nor sales? Enough of the malarkey imo. This isn’t someone’s garage type biz here. They raised a tremendous amount of capital. Time to ship up or ship out.

The alleged AI- imo is their Hail Mary to try and jumpstart something. Unless - the new temp president Peterson with a background from Boeing can quickly turn this around or imo their looking at possible another RS if market starts seeing they can’t execute and PPS once again sinks below a dollar again.

THEY NEED SALES. Something. Can’t go that road again or this thing is over. The capital institutional investors won’t screw around.

They better do something and fast or the 25% reduction in workforce is a who cares deal. SHOW THE MARKET SALES, SHOW THE MARKET THEY CAN EXECUTE. SHOW US EXOSKELETON SUITS WITH SALES.

No more talk. No more blue sky. Execute get sales or move to OTCBB and come back if and when their actually making sales and exo suits.

No way was I buying in. Wanted to. But knew transition from a R & D into an actual manufacturing company is never easy. Especially a SPAC.

Wanted them to do well- but I wisely wanted to see what they would do. Saved a lot of money on this one. If it turns around holding my breath- then I’ll review. I think AI could be their savior. We’ll see.
👍️0
Monksdream Monksdream 9 months ago
You have obviously done some thorough research about this SPAC company
Like many of them since SPAC became a thing in 2020 they are what I would characterize as failed business models
Some have already disappeared or demoted to Cromwell Coulson’s stock market
More of the same will happen this year and the years ahead
This is now a situation of vulture traders descending on the float and then hyping the stock on social media
Musical chairs
Zero Sum Game
Mano a Mano
👍️0
TIMGZ TIMGZ 9 months ago
CONSOLIDATING IN MY OPINION!
AND JUST DID RS*******
👍️0
81vette 81vette 9 months ago
Nhod,heading to ZERO BORROW,only 20k remaining to borrow,
👍️0
maverick one maverick one 9 months ago
Just my opinions & observations.
Been observing since went public with SPAC.
Their facing a serious uphill battle imo.
A recent 1-6 RS never a good thing.
Would be delisted from Nasdaq if not.
Burnt through 100’s of millions from SPAC.
Still no exoskeleton suits or sales.
Closed RE2 Pittsburg facility from merge.
Withdrew guidance - TERRIBLE.
Temp CEO had to step in from board.
Allgood is out as CEO.
RS PPS from $1.87 to $1.45 first day.
Barely trading at $1.45 range to $1.55 lately.
I smell a shorty position to bring PPS lower.
They can’t afford a 2nd RS- have to keep $1+.
Good concept- terrible execution from R & D.
Acquisition of RE2 I question it more now.
Need more capable engineers.
They save $3 million relocating. But do what?
Exoskeleton needs to be executed.
If no exo- and no sales- this could be on OTC.

Potential yes- it always was that- still has it.

But this is going to be a tough tough rest of year and into 24’ and throughout. If they don’t get sales and production of exoskeleton suits ramped up - stop talking and actually start executing - then this will continue to spiral and spiral in PPS.

Man I’d be upset if I invested previously - but I saw it was R & D, completely trying to transition into manufacturing and KNEW to stay so far away from this I could possibly get - until it executes and get sales and started to look like a manufacturing conpany with robust sales. Because it’s been looking like instead of just a wannabe showing up at expos with suits and saying “hey how cool is this?”

No more talk - Sarcos needs to get sales of exo suits and i imagine their biggest investors are likely giving the Mgmt a big side-eyes lately. We’re talking institutional types with 100’s of millions into this SPAC. They want to see and demand a return on their investment. They won’t wait around forever here.
👍️0
Monksdream Monksdream 9 months ago
STRC new 52 week low
👍️0
Triple nickle Triple nickle 10 months ago
Come on gooooo
👍️0
solidgold solidgold 1 year ago
Hello everyone. Got in today. GLTA.
👍️0
$theDDmessiah $theDDmessiah 1 year ago
;)
👍️0
Tiger Money Tiger Money 1 year ago
Cool
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
JUST WATCH WHAT I POST
👍️0
Tiger Money Tiger Money 1 year ago
What is your fav now? I love REII heading into next week but it will probably drop knowing my luck. Thanks
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
LOVE ALL MY STOCKS
👍️0
Tiger Money Tiger Money 1 year ago
You love something? Too funny. I’m buying then :)
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
STRC....LOVE THIS COMPANY.....AI ROBOTICS!
👍️0
MADDSTACKER MADDSTACKER 3 years ago
Future $100 + easy
Military
Oil and gas
Where house
I could go on for ever …. ROBOTS ARE THE FUTURE
👍️0
mlkrborn mlkrborn 12 years ago
-Surgical Express to be acquired in merger with Synergy Health for $3.70 per share in cash (stock halted) (STRC) 3.77 : Synergy Health, a global provider of outsourced sterilization services to the medical device market and healthcare sector, and SRI/Surgical Express (STRC) announced they have entered into a definitive merger agreement. Under the terms of the agreement, a subsidiary of Synergy Health will acquire all of the outstanding shares of common stock of SRI for $3.70 per share in cash through a cash tender offer followed by a merger. The transaction is valued in the aggregate at approximately $25.06 mln in equity value and $38.45 mln in enterprise value. The cash consideration represents a premium of approximately 17% to SRI's closing share price on September 13, 2011, the last trading day before SRI announced that it would explore strategic alternatives. The agreement has been unanimously approved by each company's Board of Directors.
👍️0
analogdog analogdog 16 years ago
Load time methinks... white candle tomorrow confirms reversal.
👍️0
analogdog analogdog 16 years ago
Should have only lost 30 - 40 cents a share.

Down a buck and still heading down. Find the bottom.
👍️0
analogdog analogdog 16 years ago
SRI Surgical Reports Third Quarter 2007 Financial Results
Monday November 5, 6:16 pm ET

TAMPA, Fla.--(BUSINESS WIRE)--SRI/Surgical Express, Inc. (Nasdaq:STRC - News), a leading provider of reusable and disposable surgical products and services for the healthcare industry, today announced financial results for the third quarter ended September 30, 2007.

For the third quarter of 2007, SRI Surgical reported total revenue of $23,151,000, an increase of $40,000 from the third quarter of 2006. Net loss for the third quarter of 2007 was $645,000 or $0.10 per basic and diluted common share compared to net loss of $239,000 or $0.04 per basic and diluted common share reported for the third quarter of 2006. For the first nine months of 2007, SRI Surgical reported total revenue of $70,245,000, an increase of $211,000 from the first nine months of 2006. Net loss for the first nine months of 2007 was $1,575,000 or $0.25 per basic and diluted common share compared to net loss of $1,319,000 or $0.21 per basic and diluted common share reported for the same period of 2006.

👍️0

Your Recent History

Delayed Upgrade Clock